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Masson’s intravascular hemangioma masquerading
as effort thrombosis
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An otherwise healthy 55-year-old white woman had acute onset of right arm swelling. No precipitating factors were
identified. Venograms revealed an occluded subclavian vein, and catheter-directed thrombolysis was performed. After
lysis a persistent residual intraluminal filling defect was identified, with persistent symptoms. Partial claviculectomy was
performed, the mass was removed, and patch venoplasty carried out, with good outcome. Pathologic analysis demon-
strated the mass to be a Masson’s hemangioma, a papillary proliferation of thin-walled capillaries intimately associated
with thrombus. Considered a benign intravascular lesion, the treatment of choice is complete excision. (J Vasc Surg
2004;40:812-4.)CASE REPORT
An otherwise healthy 55-year-old white woman had acute
onset of right arm swelling, present for 7 days before presentation.
The patient denied trauma, malignancy, central venous catheter-
ization, or any known hypercoagulable state, although as a school-
teacher she spent considerable time writing on a blackboard.
Physical examination revealed a swollen right upper extremity with
an intact arterial supply, and duplex scans demonstrated subclavian
vein occlusion with extensive collaterals.
A diagnosis of effort thrombosis at the costoclavicular junction
was made, and the patient was scheduled to undergo venography,
lysis, and probably thoracic outlet decompression.
Catheter-directed thrombolysis with tissue plasminogen acti-
vator was only partially successful, leaving a residual intraluminal
filling defect (Fig 1). Therefore a partial claviculectomy was per-
formed for direct access to the vein, removal of the mass, and patch
venoplasty, followed by postoperative anticoagulation therapy.
After 2 months balloon venoplasty was required because of a
stricture just proximal to the original patch end point that was
causing mild recurrent edema, but the patient has remained symp-
tom-free with an ultrasonically normal vein at follow-up of 1 year.
The gross appearance of the excised mass was consistent with
well-organized thrombus (Fig 2), but pathologic analysis demon-
strated tissue rather than thrombus. Histologic analysis revealed
numerous small papillary structures and complex vascular spaces
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doi:10.1016/j.jvs.2004.07.035812lined by a single layer of attenuated endothelial cells (Figs 3 and 4),
and the final pathologic diagnosis was Masson’s hemangioma.
DISCUSSION
First described in 1923 by Pierre Masson in an ulcer-
ated hemorrhoidal vein, Masson hemangioma remains a
rare disorder. It is a locally occurring benign tumor, almost
always intravascular, and seems to be clearly distinct from
an organizing thrombus. From the time of its initial de-
scription it has been referred to by various eponyms, includ-
ing Masson’s tumor, Masson’s hemangioma, Masson’s in-
travascular hemangioendothelioma, intravascular papillary
endothelial hyperplasia, or reactive papillary endothelial
hyperplasia.1 It occurs intracranially, in the thyroid gland,
the breast, as a neck mass, in the external jugular vein,
within the substance of the tongue, and within the oral
cavity. It has also been identified as a cause of facial nerve
palsy.2-9
Presentation typically is determined by the site at which
it occurs. If intracranial, it presents as a space-occupying
lesion, variably producing headache, seizure, intracranial
hypertension, diplopia, or hearing loss.10 While Masson’s
hemangioma has been found within or surrounding the
external jugular vein, the external iliac vein and hemor-
rhoidal varicosities are the only other vessels in which it has
been reported to occur.1,11 From the vascular surgeon’s
point of view, it typically is manifested as an intraluminal
filling defect based on an endothelial surface, almost always
in a vein, producing venous thrombosis, obstruction, or
varicose vein dilation. Some authors mention “arterial”
involvement,1,12 but we could find no primary sources to
support this.
Gray scale duplex scans or angiograms should reveal the
mass, as in our patient. Color duplex scans may be able to
define an internal “net” of microvessels within the lesion,4
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more than simply a thrombus. Magnetic resonance imaging
may also be helpful; this lesion appears to enhance on
T2-weighted images, secondary to hemorrhage within the
lesion.10 This imaging method is especially important in
neurosurgical cases.
Microscopy is most important for the diagnosis. This
usually reveals numerous papillary structures with a central
hypocellular hyaline core that are lined with a single layer of
attenuated endothelial cells that show little or no atypia
(Figs 3 and 4). This distinctive histologic appearance is
sufficient for a definitive diagnosis. Immunohistochemical
confirmation may be required only if the endothelial origin
of the lesion is in question. In such cases endothelial cell
markers, such as von Willebrand factor, CD 31, factor
Fig 1. Post-lysis venogram shows residual intraluminal filling
defect.
Fig 2. Gross appearance. A well-circumscribed tan-brown mass
was removed from the wall of the subclavian vein. XIIIa, and CD 43 may be used, which would highlight the
endothelial lining around the papillary tufts. The character-
istic architecture suffices to differentiate it from thrombus,
which lacks the papillary anatomy and proliferation of en-
dothelial cells noted in Masson’s hemangioma.13
Lesions that can be difficult to differentiate from Mas-
son hemangioma include capillary hemangioma, cavernous
hemangioma, Kaposi sarcoma, and especially low-grade
angiosarcoma. Adherence to certain key features is helpful
(Table).
Two theories have been proposed to account for the
pathogenesis of this lesion. The first, originally proposed by
Masson, states that endothelial proliferation is the primary
phenomenon, whereas thrombus arises secondarily.1 In
contrast, Clearkin and Enzinger in 1976 suggested that this
papillary structure appears after a preexisting thrombus
organizes.14 On the basis of these theories and the clinical
presentation of the lesion, 3 types have been described. A
Fig 3. Mass is mainly composed of numerous small papillary
structures and anastomosing vascular spaces (lower right).
(Hematoxylin-eosin; magnification 10.)
Fig 4. Papillary structures are lined with a single layer of flattened
endothelial cells, with occasional tufting. (Hematoxylin-eosin;
magnification 100.)
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blood vessel, most commonly a vein, whereas a secondary
hemangioma arises in the setting of a preexisting vascular
malformation, such as a cavernous hemangioma or pyo-
genic granuloma. Finally, an extravascular hemangioma,
the rarest type, arises from an organizing hematoma.15
Definitive treatment recommendations are hampered by
the extreme rarity of the lesion. It is thought to behave in
benign fashion, and local recurrence after complete resection
has not been reported. When found within a vessel it has been
completely excised, with good results.4,9 At 1 year of fol-
low-up in our patient, symptoms have resolved and ultra-
sound scans demonstrate a clean vessel. The use of adjunctive
therapy for unresectable (intracranial) lesions has been de-
scribed in 2 cases. Sickler and Langford treated a lesion that
recurred 3 months after subtotal resection (in a 12-day-old
infant) with adriamycin and dacarbazine, based on the simi-
larity of this lesion to angiosarcoma.16 No follow-up was
documented in that case. In the other report, Kristof et al1
described treatment of a subtotally resected recurrent middle
cranial lesion with radiotherapy (46 Gy), which resulted in an
initial reduction in size, followed by stabilization.1 In the
absence of any other data, we suggest lifelong yearly clinical
and ultrasound surveillance.
In a practical sense, it is difficult to recommend that this
lesion be suspected when an intravascular mass is present. We
do believe that any residual intraluminal well-defined mass
after apparently successful thrombolysis should be directly
explored and removed (which appears to be curative) rather
than simply treated with balloon venoplasty or observed. The
removed segment of vessel or excised mass should be sent for
pathologic examination. The margins of resection are not of
importance, based on our review of literature, but pathologists
should be asked to examine the lesion microscopically.
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